Literature DB >> 20186989

A left hemiblock improves cardiac resynchronization therapy outcomes in patients with a right bundle branch block.

Ramesh Chandra1, Ronald Zolty, Eugen Palma.   

Abstract

BACKGROUND: The current recommendation for cardiac resynchronization therapy (CRT) in congestive heart failure (CHF) patients is based on QRS duration, not on QRS morphology. HYPOTHESIS: This study was performed to compare the effects of CRT in CHF patients with pure RBBB vs those with a coexisting left hemiblock (LHB). METHODS AND PATIENT POPULATION: A total of 271 consecutive patients who underwent CRT at Montefiore Medical Center were analyzed. Baseline ECGs were analyzed by 2 reviewers for RBBB and further classified into those with a coexisting LHB. Response to CRT was defined to be, at > or = 6 months after CRT, either an improvement in ejection fraction (EF) of at least 5%, or an improvement in New York Heart Association (NYHA) CHF class. A total of 44 patients were identified: 18 had pure RBBB and 26 had a coexisting LHB. The 2 groups were similar in respect to baseline characteristics (P > 0.05).
RESULTS: Only 4 out of 18 patients with pure RBBB compared to 18 out of 26 with LHB (P = 0.005) had an improvement in EF > or = 5%. The mean EF was - 1% in the pure RBBB group, but + 5.4% in those with LHB (P = 0.0031). Improvement in NYHA class was seen in 0 out of 18 with pure RBBB vs 7 out of 26 patients with LHB (P = 0.03).
CONCLUSION: If patients with RBBB also had LHB, their response to CRT was significantly better than if they had RBBB alone. Copyright 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20186989      PMCID: PMC6653236          DOI: 10.1002/clc.20708

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  8 in total

Review 1.  Cardiac resynchronization therapy: the issue of non-response.

Authors:  Luigi Padeletti; Alessandro Paoletti Perini; Edoardo Gronda
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

2.  Detection of interventricular dyssynchrony: An evolution of the phase analysis technique.

Authors:  Saurabh Malhotra; Diwakar Jain
Journal:  J Nucl Cardiol       Date:  2016-06-09       Impact factor: 5.952

3.  [Management of heart failure with His bundle pacing in right bundle branch block: case report].

Authors:  Jorge Gómez-Flores; Jovana Pérez-Báez; Guillermo Muñoz; Gabriela Bustillos-García; Alan García; Álvaro E Reyes-Quintero; Rosa M Ávila-Ocampo; Antonio Arias-Godínez; Manlio Márquez; Luis Colin-Lizalde; Moisés Levinstein-Jacinto; José L Morales-Velázquez; Santiago Nava
Journal:  Arch Cardiol Mex       Date:  2021

4.  Novel electrocardiographic dyssynchrony criteria that may improve patient selection for cardiac resynchronization therapy.

Authors:  Gábor Katona; András Vereckei
Journal:  J Geriatr Cardiol       Date:  2022-01-28       Impact factor: 3.327

5.  Vectorcardiographic QRS area as a predictor of response to cardiac resynchronization therapy.

Authors:  Mohammed A Ghossein; Antonius Mw van Stipdonk; Frits W Prinzen; Kevin Vernooy
Journal:  J Geriatr Cardiol       Date:  2022-01-28       Impact factor: 3.327

6.  A different cardiac resynchronization therapy technique might be needed in some patients with nonspecific intraventricular conduction disturbance pattern.

Authors:  Gábor Katona; Zsuzsanna Szelényi; Gábor Szénási; Bálint Kozman; Zsolt Rekvényi; Luca Kópházi; Zsolt Dobos; Szilvia Vereckei; András Vereckei
Journal:  J Geriatr Cardiol       Date:  2021-12-28       Impact factor: 3.327

7.  Identifying delayed left ventricular lateral wall activation in patients with non-specific intraventricular conduction delay using coronary venous electroanatomical mapping.

Authors:  A M W van Stipdonk; M Mafi Rad; J G L M Luermans; H J Crijns; F W Prinzen; K Vernooy
Journal:  Neth Heart J       Date:  2016-01       Impact factor: 2.380

8.  Echocardiographic markers of dyssynchrony as predictors of super-response to cardiac resynchronisation therapy - a pilot study.

Authors:  V A Kuznetsov; A M Soldatova; J D Kasprzak; D V Krinochkin; N N Melnikov
Journal:  Cardiovasc Ultrasound       Date:  2018-10-02       Impact factor: 2.062

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.